CVS Health Stops Administration Of JNJ COVID-19 Shot In Several Locations: CNBC

Drugstore chain CVS Health Corporation CVS is no longer offering Johnson & Johnson's JNJ COVID-19 vaccine in many of its retail locations, the company told CNBC on Wednesday.
According to CVS spokesman Mike DeAngelis, retail locations continue to offer either the Moderna Inc MRNA or Pfizer Inc PFE - BioNTech SE BNTX vaccine.
DeAngelis said the change was implemented "several weeks ago and helps us manage our vaccine supply across the chain, both in our pharmacies and clinics."
He added that the Johnson & Johnson vaccine is still offered at almost 1,000 of its MinuteClinic locations in 25 states and Washington, D.C.
The Johnson & Johnson vaccine was touted as a potential game-changer when it was initially authorized, being a single-dose shot, and can be stored at normal refrigerator temperatures.
But the vaccine has been beset by production issues and concerns about its effectiveness against the delta variant.
Price Action: CVS shares are down 2.4% at $79.63 during the market session on the last check Thursday.
Photo by Johaehn from Pixabay